Advertisement

Exocrine Pancreas

Endocrine tumors arising from the islets of Langerhans and carcinoid tumors are not included
  • American Joint Committee on Cancer

Summary of Changes

The T classification reflects the distinction between potentially resectable (T3) and locally advanced (T4) primary pancreatic tumors.

Stage grouping has been changed to allow Stage III to signify unresectable, locally advanced pancreatic cancer, while Stage IV is reserved for patients with metastatic disease.

Keywords

Pancreatic Cancer Compute Tomog Acinar Cell Carcinoma Mucinous Cystadenocarcinoma Positive Peritoneal Cytology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Albores-Saavedra J, Heffess C, Hruban RH, et al: Recommendations for the reporting of pancreatic specimens containing malignant tumors. Am J Clin Pathol 111:304–307, 1999PubMedGoogle Scholar
  2. Association of Directors of Anatomic and Surgical Pathology: Recommendations for the reporting of pancreatic specimens containing malignant tumors. Hum Pathol 29:893–895, 1998Google Scholar
  3. Birkmeyer JD, Finlayson SR, Tosteson AN, et al: Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery 125:250–256, 1999PubMedCrossRefGoogle Scholar
  4. Birkmeyer JD, Warshaw AL, Finlayson SR, et al: Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 126:178–183, 1999PubMedCrossRefGoogle Scholar
  5. Bold RJ, Charnsangavej C, Geary KR, et al: Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. J Gastrointest Surg 3:233–243, 1999PubMedCrossRefGoogle Scholar
  6. Compton CC, Henson DE: Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Arch Pathol Lab Med 121:1129–1136, 1997PubMedGoogle Scholar
  7. Conlon KC, Klimstra DS, Brennan MF: Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathologic analysis of 5-year survivors. Ann Surg 223:273–279, 1996PubMedCrossRefGoogle Scholar
  8. Cubilla AL, Fitzgerald PJ: Tumors of the exocrine pancreas. In Atlas of tumor pathology, 2nd series, facicle 19, Washington DC: Armed Forces Institute of Pathology, 1984Google Scholar
  9. Cubilla AL, Fortner J, Fitzgerald PJ. Lymph node involvement in carcinoma of the head of the pancreas area. Cancer 41:880–887, 1978PubMedCrossRefGoogle Scholar
  10. Evans DB, Abbruzzese JL, Willett CG. Cancer of the pancreas. In DeVita VT, Hellman S, Rosenberg SA (Eds): Cancer, prin- | ciples and practice of oncology, 6th ed. Philadelphia: J.B. Lippincott, 2002Google Scholar
  11. Evans DB, Lee JE, Pisters PWT: Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In Nyhus LM, Baker RJ, Fischer JF (Eds.): Mastery of surgery, 3rd ed. Boston: Little, Brown, 1233–1249, 1997Google Scholar
  12. Fuhrman GM, Charnsangavej C, Abbruzzese JL, et al: Thin-section contrast-enhanced computed tomography accurately predicts resectability of malignant pancreatic neoplasms. Am J Surg 167:104–111, 1994PubMedCrossRefGoogle Scholar
  13. Geer RJ, Brennan MF: Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165:68–72, 1993PubMedCrossRefGoogle Scholar
  14. Gold EB, Goldin SB: Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin N Am 7:67–91, 1998PubMedGoogle Scholar
  15. Greenlee RT, Murray T, Bolden S, et al: Cancer statistics, 2000. CA Cancer J Clin 50:7–13, 2000PubMedCrossRefGoogle Scholar
  16. Griffin JF, Smalley SR, Jewell W: Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66:56–61, 1990PubMedCrossRefGoogle Scholar
  17. Kloppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ. Ductal adenocarcinoma of the pancreas. In Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors: Pathology and Genetics, Tumors of the Digestive System. Lyon, IARC Press, 2000, pp 221–230.Google Scholar
  18. Leach SD, Lee JE, Charnsangavej C, et al: Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85:611–617, 1998PubMedCrossRefGoogle Scholar
  19. Millikan KW, Deziel DJ, Silverstein JC, et al: Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 65:618–624, 1999PubMedGoogle Scholar
  20. Nitecki SS, Sarr MG, Colby TV, et al: Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving? Ann Surg 221:59–66, 1995PubMedCrossRefGoogle Scholar
  21. Pedrazzoli S, Bger HG, Obertop H, et al: A surgical and pathological based classification of resective treatment of pancreatic cancer. Dig Surg 16:337–345, 1999PubMedCrossRefGoogle Scholar
  22. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 4:567–579, 2000.PubMedCrossRefGoogle Scholar
  23. Staley C, Geary K, Abbruzzese J, et al: Need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 12:373–380, 1996PubMedCrossRefGoogle Scholar
  24. Suits J, Frazee R, Erickson RA: Endoscopic ultrasound and fine-needle aspiration for the valuation of pancreatic masses. Arch Surg 134:639–643, 1999PubMedCrossRefGoogle Scholar
  25. Traverso LW, Longmire WP Jr: Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 146:959–962, 1978PubMedGoogle Scholar
  26. Tyler DS, Evans DB: Reoperative pancreaticoduodenectomy. Ann Surg 219:211–221, 1994PubMedCrossRefGoogle Scholar
  27. Westerdahl J, Andren-Sandeberg A, Ihse I: Recurrence of exocrine pancreatic cancer—local or hepatic? Hepatogastroen-terology 40:384–387, 1993Google Scholar
  28. Whipple AO, Parsons WW, Mullin CR: Treatment of carcinoma of the ampulla of Vater. Ann Surg 102:763–269, 1935PubMedCrossRefGoogle Scholar
  29. Willett CG, Lewandrowski K, Warshaw AL, et al: Resection margins in carcinoma of the head of the pancreas: implications for radiation therapy. Ann Surg 217:144–148, 1993PubMedCrossRefGoogle Scholar
  30. Yeo CJ, Cameron JL, Sohn TA, et al: Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226:248–257, 1997PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • American Joint Committee on Cancer
    • 1
  1. 1.Executive OfficeChicagoUSA

Personalised recommendations